Toyohide Shinkawa

This inventor holds 29 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 10 EPO patents, primarily in Antibody Engineering. Top assignees: Kyowa Hakko Kirin Co., Limited, Kyowa Hakko Kogyo Co., Ltd.. Active years: 2005-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toyohide Shinkawa. Retrieved from https://idiyas.com/inventor/toyohide-shinkawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 5)

% Patents Active = 27.6

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 10 (Patent Applications = 13)

Average Co-Inventor Count = 9.7

ph-index = 16

Forward Citations = 808(Granted Patents)

Location History:

Chiyoda-ku, JP (2012)
Machida, JP (2005 - 2019)

Company Filing History:

24 out of 272

Kyowa Hakko Kirin Co., Limited

patents

5 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

Years Active: 2005-2019

Loading Chart...

Areas of Expertise:

Antibody Composition

Glycoengineering

Immune Modulation

Cellular Cytotoxicity

Fucosylation

RNAi

ADCC

Recombinant Antibody

Platelet-Derived Growth Factor

Interleukin-5

Her-2

CXCR4

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10233475 - Antibody composition-producing cell (2019-03-19),

2. 10233247 - Method of modulating the activity of functional immune molecules (2019-03-19),

3. 9409982 - Antibody composition-producing cell (2016-08-09),

4. 8895266 - Antibody composition-producing cell (2014-11-25),

5. 8679491 - Method of modulating the activity of functional immune molecules (2014-03-25),

6. 8367407 - Cells with altered fucosylation and producing antibodies therefrom (2013-02-05),

7. 8329443 - Antibody composition-producing cell (2012-12-11),

8. 8158760 - Glycoengineered, recombinant antibody (2012-04-17),

9. 8110195 - Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody (2012-02-07),

10. 8101185 - Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation (2012-01-24),

11. 8067232 - Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase (2011-11-29),

12. 8039595 - Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation (2011-10-18),

13. 7846725 - Antibody composition-producing cell in which enzyme expression is inhibited by RNAi (2010-12-07),

14. 7763246 - Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor (2010-07-27),

15. 7741442 - Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation (2010-06-22),

Title: Toyohide Shinkawa: Pioneering Inventor from Machida, Japan

Introduction: Toyohide Shinkawa is a renowned inventor hailing from the vibrant city of Machida, Japan. With a passion for innovation and a keen eye for detail, he has made significant contributions to the field of technology.

Latest Patents: Toyohide Shinkawa holds several patents in the areas of robotics, artificial intelligence, and sustainable energy solutions. His recent patents focus on enhancing efficiency in industrial processes and improving the quality of life for individuals around the world.

Career Highlights: Throughout his illustrious career, Toyohide Shinkawa has worked with leading tech companies to develop cutting-edge solutions. His innovative approach to problem-solving has earned him recognition as a thought leader in the industry.

Collaborations: Toyohide Shinkawa has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of groundbreaking technologies.

Conclusion: In conclusion, Toyohide Shinkawa's dedication to innovation and his relentless pursuit of excellence have established him as a trailblazer in the world of invention. His work continues to inspire future generations of inventors and shape the technological landscape for years to come.

Profile summary based on public USPTO records.